These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419 [TBL] [Abstract][Full Text] [Related]
5. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306 [TBL] [Abstract][Full Text] [Related]
6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
7. KSHV Genome Replication and Maintenance in Latency. Ueda K Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673 [TBL] [Abstract][Full Text] [Related]
8. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection. Katano H Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675 [TBL] [Abstract][Full Text] [Related]
9. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388 [TBL] [Abstract][Full Text] [Related]
10. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis. Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies. Paul AG; Chandran B; Sharma-Walia N Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332 [TBL] [Abstract][Full Text] [Related]
12. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival. Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572 [TBL] [Abstract][Full Text] [Related]
13. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus. Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227 [TBL] [Abstract][Full Text] [Related]
14. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus. Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608 [TBL] [Abstract][Full Text] [Related]
15. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275 [TBL] [Abstract][Full Text] [Related]
16. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433 [TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. Sin SH; Kang SA; Kim Y; Eason A; Tan K; An H; Dittmer DP J Virol; 2016 Feb; 90(4):2150-4. PubMed ID: 26656696 [TBL] [Abstract][Full Text] [Related]
19. Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines. Gregory SM; Wang L; West JA; Dittmer DP; Damania B J Virol; 2012 Apr; 86(7):3916-23. PubMed ID: 22278234 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis. Viejo-Borbolla A; Schulz TF AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]